{"id":"W2328702979","doi":"10.1093/annonc/mdv532.27","title":"443P Phase III trial of afatinib vs erlotinib in patients (pts) with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Afatinib; Erlotinib; Internal medicine; Clinical endpoint; Lung cancer; Oncology; Gefitinib; Progression-free survival; Randomized controlled trial; Gastroenterology; Cancer; Epidermal growth factor receptor; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008838422,0.001102331,0.001898639,0.0002772273,0.0003920266,0.001406739,0.0006852833,0.001064114,0.004342085],"category_scores_gemma":[0.0006752808,0.0004046244,0.001869188,0.0003910834,0.0006519234,0.0009811915,0.0003982679,0.002928824,0.0009373566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001104906,"about_ca_system_score_gemma":0.001111041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001549553,"about_ca_topic_score_gemma":0.005083,"domain_scores_codex":[0.999709,0.0001069495,0.00001500345,0.00005709373,0.0000288237,0.00008306978],"domain_scores_gemma":[0.9997149,0.00004596537,0.00006635318,0.00002259014,0.00002166774,0.000128448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8509344,0.007359044,0.009184264,0.0007318228,0.00337668,0.000202166,0.0001824796,0.003236066,0.01559879,0.0005231817,0.006595482,0.1020757],"study_design_scores_gemma":[0.7788066,0.1657745,0.03849071,0.00009974165,0.002676918,0.0006119696,0.0002116054,0.002905503,0.003145771,0.001415673,0.005782611,0.00007845015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928277,0.002220712,0.0001997014,0.0007949073,0.0001748567,0.0003445566,0.001312034,0.00007329145,0.002052278],"genre_scores_gemma":[0.9915896,0.001367157,0.0004676075,0.0007273969,0.0001048962,0.0003794682,0.00213406,0.00002405533,0.003205923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004342085,"threshold_uncertainty_score":0.01452571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04387169014604697,"score_gpt":0.3946091276952486,"score_spread":0.3507374375492017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}